Institutional Registry of Hyponatremia

计划入组 2,000 人 · 首次发布于 2011 年 6 月 10 日

Mask Adhesive Institutional Study

计划入组 7 人 · 首次发布于 2020 年 11 月 25 日

Multi-Institutional IMPACT Validation

计划入组 500 人 · 首次发布于 2025 年 2 月 27 日

Gene therapy(Janssen Global Services LLC)

Schizophrenia Therapeutics(Janssen Global Services LLC)

Cancer vaccine(Janssen Global Services LLC)

Mylan Institutional LLC

United States

INSTITUTIONAL CARE PHARMACY

United States

MYLAN INSTITUTIONAL INC.

United States

Femasys Raises $4.5 Million to Advance Women's Health Technologies Including FemBloc Birth Control

MAIA Biotechnology's THIO Shows Promise in Phase II Lung Cancer Trial; Institutional Investment Increases

Travere Therapeutics Pauses Enrollment in Phase 3 Homocystinuria Trial Due to Manufacturing Issues